Modulation of Ovarian Structure and Abdominal Obesity in Curcumin- and Flutamide-treated Aging FSH-R Haploinsufficient Mice
Authors:
- 1 June 2009
- journal article
- research article
- Published by Springer Nature in Reproductive Sciences
- Vol. 16 (6) , 539-550
Abstract
We have previously shown that follicle-stimulating hormone receptor haploinsufficient mice undergo early reproductive senescence with alterations in ovarian structures. The objective of this study was to treat aging (7-8 months) +/— follicle-stimulating hormone receptor mice that are destined for reproductive failure with 2 selected antiandrogens, curcumin and flutamide, to counteract deleterious effects of mild hyperandrogenemia on the ovary and metabolism. Both compounds significantly downregulated the expression of ovarian androgen receptor protein and simultaneously reduced cyclooxygenase 2 protein in the ovary. Immunolocalization of bone morphogenetic protein-15 in the ovary was enhanced considerably by curcumin and partially by flutamide in treated mice. Improved structural changes were evident in zona pellucida of curcumin-treated ovaries. Flutamide reduced p450c-17 (cyp-17 protein) enzyme expression in thecal/interstitial cells, whereas increased expression of 3β-hydroxysteroid dehydrogenase in thecal cells and granulosa-lutein cells of big follicles was apparent in curcumin-treated ovaries. Reduction in abdominal adiposity was greater in flutamide-treated mice. Taken together, our study allows the following conclusions: changes in ovarian histology and oocyte components as well as adipose tissue indicate the potential for reversing ovarian decline and metabolism because of mild hyperandrogenemia that occurs with aging in follicle-stimulating hormone receptor haploinsufficienct mice.Keywords
This publication has 38 references indexed in Scilit:
- Dopamine 5 receptor mediates Ang II type 1 receptor degradation via a ubiquitin-proteasome pathway in mice and human cellsJournal of Clinical Investigation, 2008
- Normalization of hormonal imbalances, ovarian follicular dynamics and metabolic effects in follitrophin receptor knockout miceMolecular Human Reproduction, 2007
- Use of antiandrogens as therapy for women with polycystic ovary syndromeFertility and Sterility, 2006
- The spectrum of androgen excess disordersFertility and Sterility, 2006
- RNA interference–mediated cyclooxygenase-2 inhibition prevents prostate cancer cell growth and induces differentiation: modulation of neuronal protein synaptophysin, cyclin D1, and androgen receptorMolecular Cancer Therapeutics, 2006
- Hypergonadotropic Ovarian Failure Associated with an Inherited Mutation of Human Bone Morphogenetic Protein-15 (BMP15) GeneThe American Journal of Human Genetics, 2004
- In vitro and in vivo anti‐tumoral effect of curcumin against melanoma cellsInternational Journal of Cancer, 2004
- Perimenopausal ConceptionAnnals of the New York Academy of Sciences, 2003
- Developmental and Molecular Aberrations Associated with Deterioration of Oogenesis During Complete or Partial Follicle-Stimulating Hormone Receptor Deficiency in MiceBiology of Reproduction, 2003
- Dynamics of Ovarian Development in the FORKO Immature Mouse: Structural and Functional Implications for Ovarian ReserveBiology of Reproduction, 2003